Michael Albers

Heidelberg, BW 69123, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis.

Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis.

Journal: Journal of medicinal chemistry

Published: April 16, 2025

Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Author Correction: Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Journal: Scientific reports

Published: April 07, 2022

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Journal: Scientific reports

Published: March 03, 2021

Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors.

Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 14, 2020

Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold.

Discovery of highly potent heme-displacing IDO1 inhibitors based on a spirofused bicyclic scaffold.

Journal: Bioorganic & medicinal chemistry letters

Published: October 14, 2020

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt.

Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt.

Journal: Bioorganic & medicinal chemistry letters

Published: February 14, 2020

Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.

Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.

Journal: Bioorganic & medicinal chemistry letters

Published: February 04, 2020

3-Substituted Quinolines as RORγt Inverse Agonists.

3-Substituted Quinolines as RORγt Inverse Agonists.

Journal: Bioorganic & medicinal chemistry letters

Published: February 11, 2019

Identification and biological evaluation of thiazole-based inverse agonists of RORγt.

Identification and biological evaluation of thiazole-based inverse agonists of RORγt.

Journal: Bioorganic & medicinal chemistry letters

Published: January 29, 2018

Regulation of IL-22BP in psoriasis.

Regulation of IL-22BP in psoriasis.

Journal: Scientific reports

Published: May 04, 2017

Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.

Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.

Journal: Scientific reports

Published: July 20, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026